Decrease in drug resistance in pneumococcal community-acquired pneumonia.
Obando
Ignacio
I
Arroyo
Luis
L
Sanchez-Tatay
David
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D006801:Humans; D022242:Pneumococcal Vaccines / Q000494:pharmacology / Q000627:therapeutic use; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy* / Q000453:epidemiology; D013030:Spain / Q000453:epidemiology; D013296:Streptococcus pneumoniae / Q000187:drug effects; D018440:beta-Lactam Resistance / Q000187:drug effects; D047090:beta-Lactams / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines; D047090:beta-Lactams